References
- MoranGJKrishnadasanAGorwitzRJEMERGEncy ID Net Study GroupMethicillin-resistant S. aureus infections among patients in the emergency departmentN Engl J Med2006355766667416914702
- GonzalezBETeruyaJMahoneyDHJrVenous thrombosis associated with staphylococcal osteomyelitis in childrenPediatrics200611751673167916651323
- GonzalezBEHultenKGDishopMKPulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infectionClin Infect Dis200541558359016080077
- Martínez-AguilarGAvalos-MishaanAHultenKHammermanWMasonEOJrKaplanSLCommunity-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in childrenPediatr Infect Dis J200423870170615295218
- PannarajPSHultenKGGonzalezBEMasonEOJrKaplanSLInfective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infectionClin Infect Dis200643895396016983604
- McKinnellJAMillerLGEellsSJCuiEHuangSSA systematic literature review and meta-analysis of factors associated with methicillin-resistant Staphylococcus aureus colonization at time of hospital or intensive care unit admissionInfect Control Hosp Epidemiol201334101077108624018925
- DukicVMLauderdaleDSWilderJDaumRSDavidMZEpidemics of community-associated methicillin-resistant Staphylococcus aureus in the United States: a meta-analysisPLoS One201381e5272223300988
- NaimiTSLeDellKHComo-SabettiKComparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infectionJAMA2003290222976298414665659
- HeroldBCImmergluckLCMarananMCCommunity-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing riskJAMA199827985935989486753
- DavidMZGlikmanDCrawfordSEWhat is community-associated methicillin-resistant Staphylococcus aureus?J Infect Dis200819791235124318422435
- LiuCGraberCJKarrMA population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2 004–2005Clin Infect Dis200846111637164618433335
- Al-RawahiGNReynoldsSPorterSDCommunity-associated CMRSA-10 (USA-300) is the predominant strain among methicillin-resistant Staphylococcus aureus strains causing skin and soft tissue infections in patients presenting to the emergency department of a Canadian tertiary care hospitalJ Emerg Med201038161118325716
- GonzalezBERuedaAMShelburneSAMusherDMHamillRJHultenKGCommunity-associated strains of methicillin-resistant Staphylococccus aureus as the cause of healthcare-associated infectionInfect Control Hosp Epidemiol200627101051105617006811
- HulténKGKaplanSLLamberthLBHospital-acquired Staphylococcus aureus infections at Texas Children’s Hospital, 2001–2007Infect Control Hosp Epidemiol201031218319020001603
- PasqualeTRJabrockiBSalstromSJIMPACT-HAP Study GroupEmergence of methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of late-onset nosocomial pneumonia in intensive care patients in the USAInt J Infect Dis2013176e398e40323375542
- McCaskillMLMasonEOKaplanSLHammermanWLamberthLBHulténKGIncrease of the USA300 clone among community-acquired methicillin-susceptible Staphylococcus aureus causing invasive infectionsPediatr Infect Dis J200726121122112718043449
- KaplanSLHultenKGMasonEOStaphylococcus aureus infections (coagulase-positive staphylococci)CherryJDDemmler-HarrisonGJKaplanSLSteinbachWJHotezPJTextbook of Pediatric Infectious DiseasesPhiladelphia, PAElsevier2013111131130
- FosterTJGeogheganJAGaneshVKHöökMAdhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureusNat Rev Microbiol2014121496224336184
- HairPSWardMDSemmesOJFosterTJCunnionKMStaphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3bJ Infect Dis2008198112513318544012
- HairPSEchagueCGShollAMClumping factor A interaction with complement factor I increases C3b cleavage on the bacterial surface of Staphylococcus aureus and decreases complement-mediated phagocytosisInfect Immun20107841717172720100856
- SharpJAEchagueCGHairPSStaphylococcus aureus surface protein SdrE binds complement regulator factor H as an immune evasion tacticPLoS One201275e3840722675461
- PantonPNValentineFCOStaphylococcal toxinsLancet19322195662506508
- Boyle-VavraSDaumRSCommunity-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidinLab Invest20078713917146447
- BocchiniCEHultenKGMasonEOGonzalezBEHammermanWAKaplanSLPanton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in childrenPediatrics2006117243344016452363
- GordonRJChezNJiaHThe NOSE study (nasal ointment for Staphylococcus aureus eradication): a randomized controlled trial of monthly mupirocin in HIV-infected individualsJ Acquir Immune Defic Syndr201055446647220686410
- SenthilkumarAKumarSSheagrenJNIncreased incidence of Staphylococcus aureus bacteremia in hospitalized patients with acquired immunodeficiency syndromeClin Infect Dis20013381412141611565083
- DiepBAChambersHFGraberCJEmergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with menAnn Intern Med2008148424925718283202
- DiepBAGillSRChangRFComplete genome sequence of USA300, an epidemic clone of community-acquired methicillin-resistant Staphylococcus aureusLancet2006367951273173916517273
- McNeilJCHultenKGKaplanSLSchwarzwaldHLMasonEOStaphylococcus aureus infections in HIV-positive children and adolescentsPediatr Infect Dis J201231328428622016081
- LeeNETaylorMMBancroftERisk factors for community-associated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with menClin Infect Dis200540101529153415844078
- SiberryGKFrederickTEmmanuelPMethicillin-resistant Staphylococcus aureus infections in human immunodeficiency virus- infected children and adolescentsAIDS Res Treat2012201262797423008761
- CottonMFWassermanESmitJWhitelawAZarHJHigh incidence of antimicrobial resistant organisms including extended spectrum beta-lactamase producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus in nasopharyngeal and blood isolates of HIV-infected children from Cape Town, South AfricaBMC Infect Dis200884018380900
- GroomeMJAlbrichWCWadulaJKhoosalMMadhiSACommunity-onset Staphylococcus aureus bacteraemia in hospitalised African children: high incidence in HIV-infected children and high prevalence of multidrug resistancePaediatr Int Child Health201232314014622824661
- ZarHJHansloDHusseyGThe impact of HIV infection and trimethoprim-sulphamethoxazole prophylaxis on bacterial isolates from children with community-acquired pneumonia in South AfricaJ Trop Pediatr2003492788312729288
- WoodSMShahSSBafanaMEpidemiology of methicillin-resistant Staphylococcus aureus bacteremia in Gaborone, BotswanaInfect Control Hosp Epidemiol200930878278519591580
- FavreDLedererSKanwarBCritical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infectionPLoS Pathog200952e100029519214220
- ChoJSPietrasEMGarciaNCIL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in miceJ Clin Invest201012051762177320364087
- MaherBMMulcahyMEMurphyAGNlrp-3-driven interleukin 17 production by γδT cells controls infection outcomes during Staphylococcus aureus surgical site infectionInfect Immun201381124478448924082072
- ArcherNKHarroJMShirtliffMEClearance of Staphylococcus aureus nasal carriage is T cell dependent and mediated through interleukin-17A expression and neutrophil influxInfect Immun20138162070207523529621
- BuchaczKPatelPTaylorMSyphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infectionsAIDS200418152075207915577629
- aidsinfo.nih.gov [homepage on the Internet]Guidelines for the prevention and treatment of opportunistic infections In HIV-exposed and HIV-infected Children2013AidsInfo. US Department of Human Health and Services Available from: http://aidsinfo.nih.gov/guidelinesAccessed March 12, 2014
- KlasterskyJAmeyeLMaertensJBacteraemia in febrile neutropenic cancer patientsInt J Antimicrob Agents200730Suppl 1S51S5917689933
- GopalAKFowlerVGJrShahMProspective analysis of Staphylococcus aureus bacteremia in nonneutropenic adults with malignancyJ Clin Oncol20001851110111510694564
- KangCISongJHChungDRKorean Network for Study on Infectious Diseases (KONSID)Bloodstream infections in adult patients with cancer: clinical features and pathogenic significance of Staphylococcus aureus bacteremiaSupport Care Cancer201220102371237822193772
- von EiffCBeckerKMachkaKStammerHPetersGNasal carriage as a source of Staphylococcus aureus bacteremia. Study GroupN Engl J Med20013441111611136954
- HagiwaraSMiwaAYoshidaMMethicillin-resistant Staphylococcus aureus: colonization and development of infection in patients with haematological disordersEur J Haematol19955542672717589346
- GhanemHMAbou-AliaAMAlsirafySAPrevalence of methicillin-resistant Staphylococcus aureus colonization and infection in hospitalized palliative care patients with cancerAm J Hosp Palliat Care201330437737922777410
- SrinivasanASeifriedSEZhuLIncreasing prevalence of nasal and rectal colonization with methicillin-resistant Staphylococcus aureus in children with cancerPediatr Blood Cancer20105571317132220830777
- McCullersJAWilliamsBFWuSHealthcare-Associated Infections at a Children’s Cancer Hospital, 1983–2008J Pediatric Infect Dis Soc201211263423687571
- BakhshiSPadmanjaliKSAryaLSInfections in childhood acute lymphoblastic leukemia: an analysis of 222 febrile neutropenic episodesPediatr Hematol Oncol200825538539218569840
- CastagnolaEFontanaVCavigliaIA prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantationClin Infect Dis200745101296130417968824
- SantolayaMEAlvarezAMAvilésCLAdmission clinical and laboratory factors associated with death in children with cancer during a febrile neutropenic episodePediatr Infect Dis J200726979479817721373
- McNeilJCHultenKGKaplanSLMahoneyDHMasonEOStaphylococcus aureus infections in pediatric oncology patients: high rates of antimicrobial resistance, antiseptic tolerance and complicationsPediatr Infect Dis J201332212412822976051
- SrinivasanASeifriedSZhuLStaphylococcus aureus bacteremia in pediatric patients with cancerPediatr Infect Dis J201029217217419918212
- SrinivasanASeifriedSZhuLPanton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus infections in children with cancerPediatr Blood Cancer20095371216122019731325
- TalanDAKrishnadasanAGorwitzRJEMERGEncy ID Net Study GroupComparison of Staphylococcus aureus from skin and soft-tissue infections in US emergency department patients, 2004 and 2008Clin Infect Dis201153214414921690621
- MermelLAAllonMBouzaEClinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of AmericaClin Infect Dis200949114519489710
- FerrettiGAHansenIAWhittenburgKBrownATLillichTTAshRCTherapeutic use of chlorhexidine in bone marrow transplant patients: case studiesOral Surg Oral Med Oral Pathol19876366836873295655
- DeRisoAJ2ndLadowskiJSDillonTAJusticeJWPetersonACChlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use in patients undergoing heart surgeryChest19961096155615618769511
- BleasdaleSCTrickWEGonzalezIMLylesRDHaydenMKWeinsteinRAEffectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patientsArch Intern Med2007167192073207917954801
- KassakianSZMermelLAJeffersonJAParenteauSLMachanJTImpact of chlorhexidine bathing on hospital-acquired infections among general medical patientsInfect Control Hosp Epidemiol201132323824321460508
- MillerMRNiednerMFHuskinsWCNational Association of Children’s Hospitals and Related Institutions Pediatric Intensive Care Unit Central Line-Associated Bloodstream Infection Quality Transformation TeamsReducing PICU central line-associated bloodstream infections: 3-year resultsPediatrics20111285e1077e108322025594
- Pereira PintoLde SouzaLBGordón-NúñezMAPrevention of oral lesions in children with acute lymphoblastic leukemiaInt J Pediatr Otorhinolaryngol200670111847185116914211
- PopovichKJHotaBHayesRWeinsteinRAHaydenMKEffectiveness of routine patient cleansing with chlorhexidine gluconate for infection prevention in the medical intensive care unitInfect Control Hosp Epidemiol2009301095996319712033
- GriniusLLGoldbergEBBacterial multidrug resistance is due to a single membrane protein which functions as a drug pumpJ Biol Chem19942694729998300047962000
- RouchDACramDSDiBerardinoDLittlejohnTGSkurrayRAEfflux-mediated antiseptic resistance gene qacA from Staphylococcus aureus: common ancestry with tetracycline- and sugar-transport proteinsMol Microbiol1990412205120622089219
- SmithKGemmellCGHunterISThe association between biocide tolerance and the presence or absence of qac genes among hospital-acquired and community-acquired MRSA isolatesJ Antimicrob Chemother2008611788417981834
- Truong-BolducQCVilletRAEstabrooksZAHooperDCNative efflux pumps contribute resistance to antimicrobials of skin and the ability of Staphylococcus aureus to colonize skinJ Infect Dis Epub12232013
- LauplandKBRossTGregsonDBStaphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000–2006J Infect Dis2008198333634318522502
- RichardsMJEdwardsJRCulverDHGaynesRPNosocomial infections in pediatric intensive care units in the United States. National Nosocomial Infections Surveillance SystemPediatrics19991034e3910103331
- FlorescuDFMcCartneyAMQiuFStaphylococcus aureus infections after liver transplantationInfection201240326326922124952
- Nafady-HegoHElgendyHMoghazyWEFukudaKUemotoSPattern of bacterial and fungal infections in the first 3 months after pediatric living donor liver transplantation: an 11-year single-center experienceLiver Transpl201117897698421786404
- DesaiDDesaiNNightingalePElliottTNeubergerJCarriage of methicillin-resistant Staphylococcus aureus is associated with an increased risk of infection after liver transplantationLiver Transpl20039775475912827565
- ShieldsRKClancyCJMincesLRStaphylococcus aureus infections in the early period after lung transplantation: epidemiology, risk factors, and outcomesJ Heart Lung Transplant201231111199120622986156
- Oliveira-CunhaMBowmanVdi BenedettoGOutcomes of methicillin-resistant Staphylococcus aureus infection after kidney and/or pancreas transplantationTransplant Proc20134562207221023953529
- SinghNSquierCWannstedtCKeyesLWagenerMMCacciarelliTVImpact of an aggressive infection control strategy on endemic Staphylococcus aureus infection in liver transplant recipientsInfect Control Hosp Epidemiol200627212212616465627
- BocchiniCEMasonEOHultenKGHammermanWAKaplanSLRecurrent community-associated Staphylococcus aureus infections in children presenting to Texas Children’s Hospital in Houston, TexasPediatr Infect Dis J201332111189119323877623
- FritzSAHoganPGHayekGHousehold versus individual approaches to eradication of community-associated Staphylococcus aureus in children: a randomized trialClin Infect Dis201254674375122198793
- WolachBGavrieliRRoosDBerger-AchituvSLessons learned from phagocytic function studies in a large cohort of patients with recurrent infectionsJ Clin Immunol201232345446622207252
- van den BergJMKuijpersTWEducational paper: Defects in number and function of neutrophilic granulocytes causing primary immunodeficiencyEur J Pediatr2011170111369137621968907
- SongEJaishankarGBSalehHJithpratuckWSahniRKrishnaswamyGChronic granulomatous disease: a review of the infectious and inflammatory complicationsClin Mol Allergy2011911021624140
- MouyRFischerAVilmerESegerRGriscelliCIncidence, severity, and prevention of infections in chronic granulomatous diseaseJ Pediatr19891144 Pt 15555602784499
- van den BergJMvan KoppenEAhlinAChronic granulomatous disease: the European experiencePLoS One200944e523419381301
- MargolisDMMelnickDAAllingDWGallinJITrimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous diseaseJ Infect Dis199016237237262117627
- GallinJIAllingDWMalechHLItraconazole to prevent fungal infections in chronic granulomatous diseaseN Engl J Med2003348242416242212802027
- LeungTChikKLiCShingMYuenPBone marrow transplantation for chronic granulomatous disease: long-term follow-up and review of literatureBone Marrow Transplant199924556757010482944
- ChinenJShearerWTPrimary immunodeficiencyCherryJDDemmler-HarrisonGJKaplanSLSteinbachWJHotezPJTextbook of Pediatric Infectious Diseases1Philadelphia, PAElsevier2014903920
- GrimbacherBHollandSMPuckJMHyper-IgE syndromesImmunol Rev200520324425015661034
- MogensenTHSTAT3 and the Hyper-IgE syndrome: Clinical presentation, genetic origin, pathogenesis, novel findings and remaining uncertaintiesJAKSTAT201322e2343524058807
- MilnerJDBrenchleyJMLaurenceAImpaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndromeNature2008452718877377618337720
- Cunningham-RundlesCBodianCCommon variable immunodeficiency: clinical and immunological features of 248 patientsClin Immunol1999921344810413651
- SchweizerMLFurunoJPHarrisADComparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremiaBMC Infect Dis20111127922011388
- LiuCBayerACosgroveSEClinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summaryClin Infect Dis201152328529221217178
- FreifeldAGBowEJSepkowitzKAClinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of americaClin Infect Dis2011524e56e9321258094
- RybakMLomaestroBRotschaferJCTherapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases PharmacistsAm J Health Syst Pharm2009661829819106348
- GordonCLThompsonCCarapetisJRTurnidgeJKilburnCCurrieBJTrough concentrations of vancomycin: adult therapeutic targets are not appropriate for childrenPediatr Infect Dis J201231121269127122828642
- HerigonJCHershALGerberJSZaoutisTENewlandJGAntibiotic management of Staphylococcus aureus infections in US children’s hospitals, 1999–2008Pediatrics20101256e1294e130020478934
- Martinez-AguilarGHammermanWAMasonEOJrKaplanSLClindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in childrenPediatr Infect Dis J200322759359812867833
- HyunDYMasonEOForbesAKaplanSLTrimethoprim-sulfamethoxazole or clindamycin for treatment of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infectionsPediatr Infect Dis J2009281575919057459
- WilliamsDJCooperWOKaltenbachLAComparative effectiveness of antibiotic treatment strategies for pediatric skin and soft-tissue infectionsPediatrics20111283e479e48721844058
- JantauschBADevilleJAdlerSLinezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogensPediatr Infect Dis J200322Suppl 9S164S17114520142
- MoschoviMTrimisGTsotraMEfficacy and safety of linezolid in immunocompromised children with cancerPediatr Int201052569469820149126
- ArduraMIMejíasAKatzKSRevellPMcCrackenGHJrSánchezPJDaptomycin therapy for invasive Gram-positive bacterial infections in childrenPediatr Infect Dis J200726121128113218043450
- PalmaDMGiordanoSNeville CracchioloAZangaraVCoffaroGTetamoRDaptomycin in the treatment of invasive Gram-positive bacterial infections in children: personal experienceMinerva Pediatr201365217317823612262
- FileTMLowDEEckburgPBIntegrated analysis of FOCUS 1 and FOCUS 2 : randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumoniaClin Infect Dis201051121395140521067350
- CoreyGRWilcoxMHTalbotGHThyeDFriedlandDBaculikTCANVAS 1 investigators. CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infectionsJ Antimicrob Chemother201065Suppl 4iv41iv5121115454
- ManuelOLienDWeinkaufJHumarACobosIKumarDMethicillin-resistant Staphylococcus aureus infection after lung transplantation: 5-year review of clinical and molecular epidemiologyJ Heart Lung Transplant200928111231123619782613
- GuptaMRValentineVGWalkerJEJrClinical spectrum of gram-positive infections in lung transplantationTranspl Infect Dis200911542443119659672
- BouchutJCStammDBoillotOLepapeAFloretDPostoperative infectious complications in paediatric liver transplantation: a study of 48 transplantsPaediatr Anaesth2001111939811123739
- GeorgeDLArnowPMFoxASBacterial infection as a complication of liver transplantation: epidemiology and risk factorsRev Infect Dis19911333873961866541
- ChenMKallenbergCGANCA-associated vasculitides – advances in pathogenesis and treatmentNat Rev Rheumatol201061165366420924413